Literature DB >> 29165427

Sphingolipids and their metabolism in physiology and disease.

Yusuf A Hannun1, Lina M Obeid1,2.   

Abstract

Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many functions, which rivals, if not exceeds, that of the genome or proteome. These results highlight critical roles for bioactive sphingolipids in most, if not all, major cell biological responses, including all major cell signalling pathways, and they link sphingolipid metabolism to key human diseases. Nevertheless, the fairly nascent field of bioactive sphingolipids still faces challenges in its biochemical and molecular underpinnings, including defining the molecular mechanisms of pathway and enzyme regulation, the study of lipid-protein interactions and the development of cellular probes, suitable biomarkers and therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29165427      PMCID: PMC5902181          DOI: 10.1038/nrm.2017.107

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  178 in total

1.  Dual functions of the trans-2-enoyl-CoA reductase TER in the sphingosine 1-phosphate metabolic pathway and in fatty acid elongation.

Authors:  Takeshi Wakashima; Kensuke Abe; Akio Kihara
Journal:  J Biol Chem       Date:  2014-07-21       Impact factor: 5.157

2.  Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.

Authors:  Michael B Dinkins; John Enasko; Caterina Hernandez; Guanghu Wang; Jina Kong; Inas Helwa; Yutao Liu; Alvin V Terry; Erhard Bieberich
Journal:  J Neurosci       Date:  2016-08-17       Impact factor: 6.167

3.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

4.  Acid ceramidase is associated with an improved prognosis in both DCIS and invasive breast cancer.

Authors:  Nicole Sänger; Eugen Ruckhäberle; Balazs Györffy; Knut Engels; Tomas Heinrich; Tanja Fehm; Anna Graf; Uwe Holtrich; Sven Becker; Thomas Karn
Journal:  Mol Oncol       Date:  2014-07-31       Impact factor: 6.603

5.  Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.

Authors:  Jonathan Y Xia; William L Holland; Christine M Kusminski; Kai Sun; Ankit X Sharma; Mackenzie J Pearson; Angelika J Sifuentes; Jeffrey G McDonald; Ruth Gordillo; Philipp E Scherer
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

6.  Ceramides and glucosylceramides are independent antagonists of insulin signaling.

Authors:  Jose A Chavez; M Mobin Siddique; Siew Tein Wang; Jianhong Ching; James A Shayman; Scott A Summers
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

7.  Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.

Authors:  Louise van der Weyden; Mark J Arends; Andrew D Campbell; Tobias Bald; Hannah Wardle-Jones; Nicola Griggs; Martin Del Castillo Velasco-Herrera; Thomas Tüting; Owen J Sansom; Natasha A Karp; Simon Clare; Diane Gleeson; Edward Ryder; Antonella Galli; Elizabeth Tuck; Emma L Cambridge; Thierry Voet; Iain C Macaulay; Kim Wong; Sarah Spiegel; Anneliese O Speak; David J Adams
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

8.  Functional implications of novel human acid sphingomyelinase splice variants.

Authors:  Cosima Rhein; Philipp Tripal; Angela Seebahn; Alice Konrad; Marcel Kramer; Christine Nagel; Jonas Kemper; Jens Bode; Christiane Mühle; Erich Gulbins; Martin Reichel; Cord-Michael Becker; Johannes Kornhuber
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Acid sphingomyelinase serum activity predicts mortality in intensive care unit patients after systemic inflammation: a prospective cohort study.

Authors:  Matthias Kott; Gunnar Elke; Maike Reinicke; Supandi Winoto-Morbach; Dirk Schädler; Günther Zick; Inéz Frerichs; Norbert Weiler; Stefan Schütze
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

10.  Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function.

Authors:  Aimee E Hodson; Trevor S Tippetts; Benjamin T Bikman
Journal:  Cardiovasc Diabetol       Date:  2015-12-18       Impact factor: 9.951

View more
  398 in total

1.  Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.

Authors:  Su-Fern Tan; Wendy Dunton; Xin Liu; Todd E Fox; Samy A F Morad; Dhimant Desai; Kenichiro Doi; Mark R Conaway; Shantu Amin; David F Claxton; Hong-Gang Wang; Mark Kester; Myles C Cabot; David J Feith; Thomas P Loughran
Journal:  J Lipid Res       Date:  2019-04-08       Impact factor: 5.922

2.  A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity.

Authors:  Mengqiao Cui; Rong Ying; Xue Jiang; Gang Li; Xuanjun Zhang; Jun Zheng; Kin Yip Tam; Bin Liang; Anbing Shi; Verena Göbel; Hongjie Zhang
Journal:  J Neurosci       Date:  2019-05-28       Impact factor: 6.167

3.  Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.

Authors:  Devesh C Pant; Imen Dorboz; Agatha Schluter; Stéphane Fourcade; Nathalie Launay; Javier Joya; Sergio Aguilera-Albesa; Maria Eugenia Yoldi; Carlos Casasnovas; Mary J Willis; Montserrat Ruiz; Dorothée Ville; Gaetan Lesca; Karine Siquier-Pernet; Isabelle Desguerre; Huifang Yan; Jingmin Wang; Margit Burmeister; Lauren Brady; Mark Tarnopolsky; Carles Cornet; Davide Rubbini; Javier Terriente; Kiely N James; Damir Musaev; Maha S Zaki; Marc C Patterson; Brendan C Lanpher; Eric W Klee; Filippo Pinto E Vairo; Elizabeth Wohler; Nara Lygia de M Sobreira; Julie S Cohen; Reza Maroofian; Hamid Galehdari; Neda Mazaheri; Gholamreza Shariati; Laurence Colleaux; Diana Rodriguez; Joseph G Gleeson; Cristina Pujades; Ali Fatemi; Odile Boespflug-Tanguy; Aurora Pujol
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

4.  Real-time lipid patterns to classify viable and necrotic liver tumors.

Authors:  Pierre-Maxence Vaysse; Heike I Grabsch; Mari F C M van den Hout; Marc H A Bemelmans; Ron M A Heeren; Steven W M Olde Damink; Tiffany Porta Siegel
Journal:  Lab Invest       Date:  2021-01-22       Impact factor: 5.662

5.  Activation of atypical protein kinase C by sphingosine 1-phosphate revealed by an aPKC-specific activity reporter.

Authors:  Taketoshi Kajimoto; Alisha D Caliman; Irene S Tobias; Taro Okada; Caila A Pilo; An-Angela N Van; J Andrew McCammon; Shun-Ichi Nakamura; Alexandra C Newton
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

6.  ACBD3 is required for FAPP2 transferring glucosylceramide through maintaining the Golgi integrity.

Authors:  Jing Liao; Yuxiang Guan; Wei Chen; Can Shi; Dongdong Yao; Fengsong Wang; Sin Man Lam; Guanghou Shui; Xinwang Cao
Journal:  J Mol Cell Biol       Date:  2019-02-01       Impact factor: 6.216

7.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

8.  ATP binding cassette family A protein 1 determines hexosylceramide and sphingomyelin levels in human and mouse plasma.

Authors:  Jahangir Iqbal; Meghan T Walsh; Samar M Hammad; Marina Cuchel; Daniel J Rader; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

9.  Lithium Hydroxide Hydrolysis Combined with MALDI TOF Mass Spectrometry for Rapid Sphingolipid Detection.

Authors:  Anh Tran; Liting Wan; Zhenbo Xu; Janette M Haro; Bing Li; Jace W Jones
Journal:  J Am Soc Mass Spectrom       Date:  2020-10-30       Impact factor: 3.109

10.  Serum sphingolipids and incident diabetes in a US population with high diabetes burden: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Guo-Chong Chen; Jin Choul Chai; Bing Yu; Gregory A Michelotti; Megan L Grove; Amanda M Fretts; Martha L Daviglus; Olga L Garcia-Bedoya; Bharat Thyagarajan; Neil Schneiderman; Jianwen Cai; Robert C Kaplan; Eric Boerwinkle; Qibin Qi
Journal:  Am J Clin Nutr       Date:  2020-07-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.